450
Views
11
CrossRef citations to date
0
Altmetric
Articles

Uses, Effects and Toxicity of Synthetic Cannabinoids from the Perspective of People with Lived Experiences

, Ph.D.ORCID Icon, , B.Sc., , M.D.ORCID Icon & , Ph.D.ORCID Icon
Pages 237-247 | Received 31 May 2019, Accepted 19 Nov 2019, Published online: 06 Feb 2020

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (1)

Blessing N. Marandure, Samson Mhizha & Amanda Wilson. (2023) “Spice Was Made, by the Devil Himself”: A Thematic Analysis of the Experience of an Addiction to Synthetic Cannabinoids. Journal of Psychoactive Drugs 55:3, pages 321-329.
Read now

Articles from other publishers (10)

Sarah A. Hindson, Rachael C. Andrews, Michael J. Danson, Marc W. van der Kamp, Amy E. Manley, Oliver B. Sutcliffe, Tom S. F. Haines, Tom P. Freeman, Jennifer Scott, Stephen M. Husbands, Ian S. Blagbrough, J. L. Ross Anderson, David R. Carbery & Christopher R. Pudney. (2023) Synthetic cannabinoid receptor agonists are monoamine oxidase‐A selective inhibitors . The FEBS Journal 290:12, pages 3243-3257.
Crossref
Wafaa M. Abdelmoneim, Marwa H. Bakr, Nagwa M. Ghandour, Marwa Kh. Mohammed, Mohamed Fawzy, Abdelrahman G. Ramadan & Nora Z. Abdellah. (2023) Cytotoxicity associated with acute and chronic administration of synthetic cannabinoids “Strox” in the brain, liver, heart, and testes of male albino rats: histological and immunohistochemical study. Egyptian Journal of Forensic Sciences 13:1.
Crossref
Wafaa M. Abdelmoneim, Nagwa M. Ghandour, Mohamed Fawzy, Marwa Kh. Mohammed, Abdelrahman G. Ramadan & Nora Z. Abdellah. (2022) Clinical pattern of synthetic cannabinoids users in Upper Egypt: cross-sectional study. Middle East Current Psychiatry 29:1.
Crossref
Hugo López-Pelayo, Santiago Madero, Lies Gremeaux, Sanna Rönkä & João Matias. (2022) Synthetic Cannabinoids and Cannabis: How the Patterns of Use Differ: Results from the European Web Survey on Drugs. International Journal of Mental Health and Addiction.
Crossref
Kunshan Gu, Shiyang Qin, Ying Zhang, Wenfang Zhang, Guobin Xin, Boyuan Shi, Jifen Wang, Yuanfeng Wang & Jianghai Lu. (2022) Metabolic profiles and screening tactics for MDMB-4en-PINACA in human urine and serum samples. Journal of Pharmaceutical and Biomedical Analysis 220, pages 114985.
Crossref
Pierce Kavanagh, Alexandr Pechnikov, Ivan Nikolaev, Geraldine Dowling, Mariia Kolosova & Andrej Grigoryev. (2022) Detection of ADB-BUTINACA Metabolites in Human Urine, Blood, Kidney and Liver. Journal of Analytical Toxicology 46:6, pages 641-650.
Crossref
Sulaf Assi, Aidan Keenan & Abdullah Al Hamid. (2022) Exploring e-psychonauts perspectives towards cocaine effects and toxicity. Substance Abuse Treatment, Prevention, and Policy 17:1.
Crossref
Nina SkokoM.M., Darija SazdanićB.B., Isidora SamojlikN.N., Bela KolaršŠ.Š., Ana MiljkovićR.R. & Vesna Mijatović-JovinM.M.. (2022) Factors influencing knowledge of synthetic cannabinoids: Study conducted among future healthcare professionals. Hospital Pharmacology - International Multidisciplinary Journal 9:3, pages 1207-1214.
Crossref
Philip Wiredu Addo, Vincent Desaulniers Brousseau, Victorio Morello, Sarah MacPherson, Maxime Paris & Mark Lefsrud. (2021) Cannabis chemistry, post-harvest processing methods and secondary metabolite profiling: A review. Industrial Crops and Products 170, pages 113743.
Crossref
Oya YETER. (2020) Simultaneous determination of 4F-MDMB BINACA, a new synthetic cannabinoid, and its metabolites in human blood samples by LC-MS/MS. Journal of the Turkish Chemical Society Section A: Chemistry 7:3, pages 827-832.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.